MDT - Medtronic plc
| Previous close | 84.73 |
| Open | 84.54 |
| Bid | 84.22 x 1200 |
| Ask | 84.85 x 800 |
| Day's range | 82.77 - 84.64 |
| 52-week range | 78.29 - 100.15 |
| Volume | 6,798,040 |
| Avg. volume | 5,676,367 |
| Market cap | 112.952B |
| Beta (3Y monthly) | 0.69 |
| PE ratio (TTM) | 23.78 |
| EPS (TTM) | 3.54 |
| Earnings date | 23 May 2019 |
| Forward dividend & yield | 2.00 (2.20%) |
| Ex-dividend date | 2019-03-21 |
| 1y target est | 103.28 |
GlobeNewswire•5 days agoMedtronic Data Expands on Key Aortic Solutions for Challenging Anatomies
April 17, 2019 - Medtronic plc (MDT) today released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant(TM) II/IIs stent graft system in combination with Heli-FX(TM) EndoAnchor(TM) implants and for the Valiant Navion(TM) thoracic stent graft system for thoracic endovascular repair (TEVAR). The data presented at the Charing Cross Symposium in London expands on the commitment to treat increasingly challenging aortic anatomies.
- GlobeNewswire•5 days ago
Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease
April 17, 2019 - Medtronic plc (MDT) today announced five-year outcomes from the VeClose Extension Study. The new data demonstrate durable and consistent long-term outcomes of the Medtronic VenaSeal(TM) Closure System in treating patients with chronic venous disease. The VeClose Extension Study is a follow-on study with the purpose of evaluating long-term outcomes at five years post-treatment with the VenaSeal Closure System.
- Motley Fool•8 days ago
3 Top Diabetes Stocks to Watch in April
Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now.
- Zacks•9 days ago
Medtronic's (MDT) Study Shows Positive Results of TDD Use (revised)
The outcomes of the study demonstrates that patients on TDD along with CMM witnessed some major benefits compared to those on CMM alone.
- Zacks•12 days ago
Medtronic's (MDT) Study Shows Positive Results of TDD Use
The outcomes of the study, conducted by Medtronic (MDT), demonstrates that patients on TDD along with CMM witnessed some major benefits compared to those on CMM alone.
- Zacks•12 days ago
Medtronic (MDT) Inks Value-Based Deal for Guardian Connect
Medtronic's (MDT) Guardian Connect system can now be accessed via a Blue Cross and Blue Shield of Minnesota member's pharmacy benefit.
- GlobeNewswire•14 days ago
New Data Show Encouraging Economic Outcomes for Medtronic HeartWare(TM) HVAD(TM) System
Positive HVAD LATERAL TM Study Results Also Now Published in The Journal of Heart and Lung Transplantation DUBLIN and ORLANDO, Fla. - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced data showing ...
- Zacks•14 days ago
Medtronic's New Data for HVAD System to Boost CRHF Segment
Medtronic's (MDT) latest data is expected to boost top-line contributions from the HeartWare HVAD System within the CRHF suite.
- GlobeNewswire•14 days ago
New Study Finds Targeted Drug Delivery (TDD) is Associated with a Reduction in Health Care Utilization and Cost for Cancer Pain Patients
Savings Are Driven by Fewer Inpatient Visits, Shorter Inpatient Length of Stay, and Fewer Emergency Department Visits DUBLIN - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced results of a study ...
- GlobeNewswire•16 days ago
Medtronic HeartWare(TM) HVAD(TM) System Demonstrates Reduction in Total Strokes, Disabling Strokes and Stroke-Related Mortality with Blood Pressure Management
Company Has Initiated a Post-Approval Study of Heart Failure Management Best Practices to Further Demonstrate Improved Patient Outcomes DUBLIN and ORLANDO, Fla. - April 5, 2019 - Medtronic plc (NYSE:MDT) ...
- Zacks•19 days ago
Nevro (NVRO) Plagued by Issues in Australia & Stiff Rivalry
Nevro's (NVRO) international sales get affected by weakness in Australia.
- Zacks•19 days ago
Medtronic's Diabetes Arm Grows Strong, Rising Costs Ail
Medtronic (MDT) is highly optimistic about its foray into the $1-billion standalone CGM market with its Guardian Connect.
- Zacks•20 days ago
The Zacks Analyst Blog Highlights: Chevron, IBM, Medtronic, lululemon and Carnival
The Zacks Analyst Blog Highlights: Chevron, IBM, Medtronic, lululemon and Carnival
- Zacks•20 days ago
Top Analyst Reports for Chevron, IBM & Medtronic
Top Analyst Reports for Chevron, IBM & Medtronic
- Zacks•26 days ago
Medtronic Unveils MedTech Innovation Accelerator in China
The MedTech Innovation Accelerator is a collaborative initiative on part of Medtronic (MDT) to foray into the Chinese med-tech innovation market via venture investments, incubation and acceleration.
- Simply Wall St.•27 days ago
Read This Before Buying Medtronic plc (NYSE:MDT) Shares
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! We've lost count of how many times insiders have accumulatedRead More...
- GlobeNewswire•27 days ago
Medtronic Launches Medtech Innovation Accelerator in Shanghai
March 25, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced the launch of the Medtronic MedTech Innovation Accelerator in Pujiang International Science and Technology City at Minhang District, Shanghai. The new collaborative innovation platform will provide services for MedTech start-ups worldwide, address unmet clinical needs in China, and welcome its initial roster of portfolio companies.
- TechCrunch•last month
Homeland Security warns of critical flaws in Medtronic defibrillators
Homeland Security has issued a warning for a set of critical-ratedvulnerabilities in Medtronic defibrillators that put the devices at risk ofmanipulation
- Reuters•last month
FDA says cybersecurity vulnerabilities found in some Medtronic devices
Last year, Medtronic disabled internet updates for some 34,000 CareLink programming devices that healthcare providers around the world use to access implanted pacemakers, saying the system was vulnerable to cyberattacks. Medical device makers have bolstered efforts to mitigate product security vulnerabilities in recent years following a flurry of warnings from security researchers who have identified bugs in devices like the Medtronic implant programmers.
- Zacks•last month
Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results
The use of Abbott's (ABT) HeartMate 3 pump can efficiently prolong life -term and improve the quality of life for advanced heart failure patients.
- Zacks•last month
Edwards Lifesciences Presents Positive Partner 3 Trial Data
Edwards Lifesciences (EW) expects SAPIEN 3 to gain FDA approval for the low-risk indication in late-2019.
- Zacks•last month
Why Is Medtronic (MDT) Down 1.2% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•last month
Medtronic (MDT) Releases Encouraging Evalut TAVR Result
Medtronic's (MDT) clinical study data shows that the low-risk aortic stenosis patients have special characteristics as they tend to be younger and active compared with the higher-risk equivalents.
- Barrons.com•last month
How You Can Invest Like an Activist
OK, you can’t build a significant stake in a company, and you won’t get a board seat. But you can still look at a stock as an activist would.
- GlobeNewswire•last month
New Clinical Trial Shows Medtronic TYRX(TM) Envelope Signficantly Reduces Major Infections in Cardiac Implantable Device Patients
Late-Breaking Trial Results Presented at ACC Scientific Sessions and Published in The New England Journal of Medicine WRAP-IT is the Largest Randomized Global Trial Ever Conducted with Cardiac Implanted ...
